Dexcom (NSDQ:DXCM) announced today that it plans to launch its G7 15 Day continuous glucose monitor (CGM) in the U.S. next ...

The Smart Basal offering with the G7 CGM. [Images courtesy of Dexcom] Dexcom (NSDQ:DXCM) announced today that the FDA cleared its Smart Basal CGM-integrated basal insulin dosing optimizer. The ...

Modular Medical (Nasdaq:MODD) announced that it has submitted its next-generation Pivot insulin pump to the FDA for clearance.

Medtronic officials today said the planned separation of its Diabetes unit (MiniMed) is on track, with future offerings also ...

The Scotland-based company develops a novel pop-up cardboard dry powder inhaler (DPI). Rather than use expensive, bulky ...